Recent Finacing
Recent Raise
Zentera Therapeutics is a clinical-stage biopharmaceutical company in China developing Zentalis-discovered oncology small-molecule therapies, including WEE1 inhibitor ZN-c3, oral SERD ZN-c5, and BCL-2 inhibitor ZN-d5.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Zentera Therapeutics.
